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Abstract
The presence of cold agglutinins (CAs) in samples intended for complete blood count (CBC) using automated haematology analysers might cause 
serious preanalytical errors. In this report we describe the case of a 90-year old female patient admitted to the Emergency department following 
trauma injuries. A blood testing on admission revealed surprisingly low red blood cell count (0.99 x 1012/L), low haematocrit (0.102 L/L) which did 
not correlate with haemoglobin concentration (100 g/L), and high erythrocytes indices (mean corpuscular haemoglobin, 101 pg; mean corpuscular 
haemoglobin concentration, 980 g/L). In the second sample, after repeated collection, almost equal results were observed. Blood smear examina-
tion under the microscope revealed clusters of erythrocytes. Cold agglutinins presence was suspected and, in order to get valid results, sample was 
warmed to 37 °C. Correction of CBC was observed. Furthermore, we performed some additional analysis to confirm the presence of CAs in this pati-
ent. The aim of this report was to present the laboratory findings in a case of CAs and propose a laboratory procedure for whole blood samples with 
suspected CAs. 
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The advent of automated haematology analysers 
has resulted in high throughput and improved ac-
curacy of complete blood count (CBC) results. 
However, various pre-analytical and analytical fac-
tors, as well as clinical conditions might affect the 
reliability of CBC results, including white blood cell 
count (WBC), red blood cell count (RBC) and RBC 
indices (MCV; mean corpuscular volume, MCH; 
mean corpuscular haemoglobin, MCHC; mean cor-
puscular haemoglobin concentration), and plate-
let count (Plt).  
Cold agglutinins (CAs) are the most commonly im-
munoglobulin (Ig) M antibodies (rarely IgA or IgG) 
directed against polysaccharide antigens located 
on the surface of erythrocytes which become acti-
vated by low temperature. The resulting antigen-
antibody complex strongly activates the classical 
complement cascade, which might cause removal 
of RBCs in the reticuloendothelial system, intravas-
cular and extravascular haemolysis (1). Cold agglu-
tinin disease (CAD) is a type of autoimmune 
haemolytic anaemia (AIHA) characterized by an im-
mune reaction against RBC self-antigens. A cold ex-
posure or a concurrent infection may be sufficient 
to trigger the clinical manifestation of disease (2). 
Cold agglutinins presence in samples intended for 
CBC analysis using automated haematology ana-
lysers might cause serious preanalytical errors. 
Most of the published reports on CAs presence are 
presented from a clinical perspective. Laboratory 
findings are usually scarce and the analytical per-
spective is often omitted. Several cases reported 
the importance of preanalytical effect of CAs on 
laboratory results, especially on CBC (3-5). The aim 
of this report is to present the laboratory findings 
found in a case of CAs and propose a laboratory 
procedure for whole blood samples with suspect-
ed CAs. 
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Case report
A 90-year old female patient was admitted to the 
Emergency department (ED) of our hospital in De-
cember 2017 after trauma injuries. Following initial 
examination and due to nature of injuries, she was 
transferred to our dislocated traumatology unit 
where further diagnostic examinations were per-
formed. 
Laboratory analyses
As a part of diagnostic processing, samples were 
referred to our laboratory for routine haematolo-
gy, coagulation, biochemistry, blood gas and urine 
analysis. 
Peripheral blood for CBC, collected by venipunc-
ture in 3.5 mL Vacuette® tube (K3EDTA, Greiner Bio-
One, Kremsmunster, Austria), was analysed on Sys-
mex XT-1800i haematology analyser (Sysmex Cor-
poration, Kobe, Japan). The results on admission 
are presented in Table 1, Sample 1. Red blood cell 
count and haematocrit (Hct) values were surpris-
ingly low and did not correlate with the haemo-
globin (Hb) concentration. Consequently, RBC indi-
ces were spuriously increased, especially MCH and 
MCHC, while Plt and WBC count seemed valid. Ad-
ditionally, the RBC results were flagged by the ana-
lyser. Because of flags which indicated RBC agglu-
tination and the obviously erroneous RBC results, 
the tube was visually checked for clumps and the 
presence of micro-aggregates was established. Af-
ter centrifugation, haemolysis of the sample was 
noted. According to our laboratory protocol, these 
results were not released to the clinician and a 
new sample was requested from the ward. 
A new whole blood sample was delivered to our 
laboratory. After visual inspection of the sample 
for clumps, we excluded their presence and CBC 
testing was repeated. The test results were almost 
equal to those measured in the first sample (Table 
1, Sample 2). Again, low RBC and Htc with high 
MCH and MCHC values were observed. The ana-
lyser’s flags were the same. Blood smear was pre-
pared, using the May-Grünwald-Giemsa stain 
(Merck, Darmstadt, Germany), and examination 
under the light microscope (Olympus BX43, Olym-
pus, Tokyo, Japan) revealed clusters of RBCs (Fig-
ure 1A). At this point, the presence of CAs was sus-
pected and the tube was incubated at 37 °C for 30 
minutes. The CBC results after incubation seemed 
corrected (Table 1, Sample 2a). Clusters of RBCs 
were not observed in the blood smear prepared 
from the warmed sample (Figure 1B). According to 
our intralaboratory procedure based on Sysmex’s 
Parameter Sample 1* Sample 2† Sample 2a‡ Sample 2b§ Reference interval
RBC (x1012/L) 0.99 1.73 2.79 2.98 3.86 - 5.08
Hb (g/L) 100 77 84 90 119 - 157
Hct(L/L) 0.102 0.169 0.252 0.277 0.356 - 0.470
MCV (fL) 103.0 97.7 90.3 93.0 83.0 - 97.2
MCH (pg) 101.0 44.5 30.1 30.2 27.4 - 33.9
MCHC (g/L) 980 456 333 325 320 - 345
RDW (%) 23.9 18.2 17.2 17.2 9.0 - 15.0
Plt (x109/L) 278 206 258 272 158 - 424
MPV (fL) 10.3 9.1 9.8 10.2 6.8 - 10.4
WBC (x109/L) 6.0 5.3 6.7 7.1 3.4 - 9.7
*First sample after admission. †Second (repeated collection) sample. ‡Second sample incubated at 37 ºC for 30 minutes. §Second 
sample with Cellpack® replaced plasma. RBC - red blood cells. Hb - haemoglobin. Hct - haematocrit. MCV - mean corpuscular 
volume. MCH - mean corpuscular haemoglobin. MCHC - mean corpuscular haemoglobin concentration. RDW - red cell distribution 
width. Plt - platelets. MPV - mean platelet volume. WBC - white blood cells.
Table 1. Laboratory values of haematology parameters at patient admission to Traumatology clinic
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document for flagging interpretation, we centri-
fuged the warmed sample for 10 min at 1800xg 
and replaced the supernatant plasma with the 
same volume of particle-free commercial diluent 
(Cellpack®, Sysmex Corporation, Kobe, Japan) (6). 
This procedure is sometimes required in cases 
with high CAs titers. The sample was well mixed 
and CBC test was run again. The results obtained 
were comparable to those obtained by incubating 
the sample at 37 °C (Table 1, Sample 2b). 
Further investigations
To confirm the presence of CAs, we performed 
some additional analyses. Direct and indirect anti-
globulin (Coombs) test using anti-IgG and anti-C3 
antibodies were performed using MONOGnost® 
monoclonal polyspecific anti-human globulin rea-
gent (Biognost, Zagreb, Croatia) and the results 
were positive for direct and negative for indirect 
antiglobulin test. The results indicated in vivo sen-
sitization of patient RBCs with IgG and/or C3 com-
ponent of complement. Furthermore, the concen-
trations of IgG, IgA, IgM, C3 and C4 component of 
complement in patient’s serum were determined 
on the Abbott Architect c8000 automated bio-
chemistry analyser (Abbott Laboratories, IL, USA). 
Only concentration of IgM was above the upper 
reference limit which indicated that CAs in this 
case might be IgM class, such as usually found in 
CAD (Table 2).
To prevent future analytical problems related to 
the presence of CAs in the patient’s sample, we in-
formed the clinical staff on the importance of im-
mediate analysis of this patient’s sample (i.e. im-
mediate sample transport after collection was in-
stituted for this sample alone). The results of hae-
matology parameters determined during the rest 
of the patient’s hospitalization period are present-
ed in Table 3. There were no further analytical 
problems when the sample was immediately 
transported to the laboratory. On the 3rd day of 
Figure 1. Peripheral blood smear, May-Grünwald-Giemsa stain, 1000x. A: Sample after repeated collection presenting with erythro-
cyte clusters. B: Sample after incubation at 37 °C for 30 minutes without showing erythrocyte clusters.
A B
Parameter Reference interval
Immunoglobulin G, g/L 13.70 5.52 - 16.31
Immunoglobulin A, g/L 1.71 0.69 - 5.17
Immunoglobulin M, g/L 4.26 0.33 - 2.93
C3 component of complement, g/L 1.07 0.83 - 1.93
C4 component of complement, g/L 0.24 0.15 - 0.57
Table 2. The patient’s laboratory results for immunoglobulins 
and component of complement concentrations
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hospitalization, to correct for anaemia, the patient 
received two doses of RBC concentrate.
What happened?
Erroneous values of RBC count and RBC-depend-
ent parameters in this case were the consequence 
of CAs presence in the patient’s sample. Cold ag-
glutinins led to RBC micro-aggregates formation, 
which resulted in inaccurately low RBC count. Con-
sequently, errors were also detectable on Htc and 
RBC indices values. Interestingly, we later found 
out that the CBC was also performed on admission 
to the ED where unusual results were not ob-
served. In fact, RBC was 3.3x1012/L, Hb 98 g/L, Htc 
0.309 L/L, MCV 93.1 fL, MCH 29.5 pg, MCHC 317 
g/L. Since this case occurred in the winter period, 
it is possible that low temperature during the 
transport from one location to other triggered ac-
tivation of CAs in this patient. 
Solution 
To solve preanalytical interference of CAs and get 
valid results, we warmed the sample at body tem-
perature in order to achieve separation of aggluti-
nated RBCs. To prevent future analytical problems, 
samples of this patient were delivered to the labo-
ratory immediately after collection and promptly 
analysed. Considering organisation at our loca-
tion, we can ensure the delivery of sample within 5 
minutes of collection so the usual transport proce-
dure at body temperature in water bath has not 
been applied. 
A proposed laboratory procedure for whole blood 
samples with suspected CAs is presented in Figure 
2. Spuriously low RBC, Hct and elevated MCV, MCH 
and, especially MCHC, as well as discrepancy be-
tween Hct, Hb and RBC results should always trig-
ger suspicion of CAs presence in blood samples. 
One of the most indicative parameters generated 
by haematology analysers is MCHC, because of its 
mode of calculation. Its abnormalities alarm the 
user that the sample has to be checked. A quick vi-
sual check of the Hb, Hct and RBC results can be 
done by applying the “Rules of Three”. The rules 
say that the value of Hb should be aproximately 
three times the value of the RBC (RBC (1012/L) x 3 ~ 
Hb (g/dL)) and the value of Hct should be aproxi-
mately three times the value of the Hb (Hb (g/dL) x 
3 ~ Hct (%)) (7). Although these rules apply only to 
specimens that have normocytic normochromic 
erythrocytes, they present a very simple and easy 
tool to detect possible samples with CAs within 
the large amount of routine samples. Effects of 
Parameter 2nd day 3rd day* 4th day 5th day 6th day
RBC (x1012/L) 2.76 3.44 3.44 3.37 3.96
Hb (g/L) 89 111 112 101 117
Hct (L/L) 0.267 0.321 0.321 0.309 0.361
MCV (fL) 96.7 93.3 93.3 91.7 91.2
MCH (pg) 32.2 32.3 32.6 30.0 29.5
MCHC (g/L) 333 346 349 327 324
RDW (%) 18.8 17.7 17.1 16.7 16.5
Plt (x109/L) 273 237 244 249 284
MPV (fL) 9.3 9.9 9.3 9.8 9.5
WBC (x109/L) 5.1 8.2 4.7 3.8 5.1
*Patient received two doses of RBC concentrate. All samples were immediately transported to the laboratory after collection. RBC 
- red blood cells. Hb - haemoglobin. Hct - haematocrit. MCV - mean corpuscular volume. MCH - mean corpuscular haemoglobin. 
MCHC - mean corpuscular haemoglobin concentration. RDW - red cell distribution width. Plt - platelet. MPV - mean platelet volume. 
WBC - white blood cells.
Table 3. Laboratory values of haematology parameters during the rest of the patient’s hospitalization period
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Figure 2. A proposed laboratory procedure for whole blood samples with suspected cold agglutinins. CBC - complete blood count. 
Hct - haematocrit. MCV - mean corpuscular volume. MCH - mean corpuscular haemoglobin. MCHC - mean corpuscular haemoglobin 
concentration. RDW - red cell distribution width. Plt - platelet. MPV - mean platelet volume. WBC - white blood cells. CAs - cold ag-
glutinins.
CAs are commonly visible on RBC count and RBC-
dependent parameters, but it is important to 
stress that effects can be also visible on Plt causing 
spuriously low Plt count and falsely increased 
mean platelet volume (MPV). Therefore, such re-
sults should also raise the suspicion on CAs pres-
ence in the blood sample. To confirm RBC or Plt 
agglutination in the sample, the best way is blood 
smear examination under the microscope. As 
shown in Figure 2, the suspected presence of CAs 
has been raised, and the next step involves re-
questing a new sample and transporting that sam-
ple immediately after collection to the laboratory. 
The tube for blood collection should be warmed 
and transported to the laboratory, without cool-
ing, at 37 °C, in an insulated container filled with 
warmed water and in a styrofoam box. The analy-
sis should be made as soon as the sample is re-
ceived in the laboratory. After the presence of CAs 
is evidenced, on the test result report informative 
comment should be incorporated. The comment 
should contain information to the clinician about 
finding CAs in the patient sample and information 
how to draw every next sample from that patient. 
In case of inability to obtain a new sample, warm-
ing the suspicious sample may be an alternative, 
but such results should be carefully interpreted, 
because it is not possible to be sure that all RBCs 
are separated after sample warming. In case of re-
porting results informative comment should also 
CBC results: ↓RBC, ↓Hct, ↑MCV,
↑MCH, ↑MCHC, ↓Plt, ↑MPV
The "Rules of Three" NOT met:
RBC (x1012/L) x 3 ~ Hb (g/dL) 
Hb (g/dL) x 3 ~ Hct (%)
Suspicion on CAs presence
in whole blood sample
Request a new sample
Collect the sample into
warmed container
and




as soon as the sample is
received in the laboratory
Report results with
informative comment
Prepare a blood smear In case of inability to obtain a new sample or
to confirm the presence of CAs





Prepare a blood smear
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contain information that results were obtained af-
ter warming the sample. Also, warming the suspi-
cious sample presents an easy evidence way of the 
presence of CAs. 
Discussion
In the presence of CAs, we found erroneously low 
RBC values and discrepancy between Hb and Hct. 
The analyser directly measures RBC, Htc and Hb 
parameters, while MCV, MCH and MCHC are calcu-
lated from measured parameters. Low RBC count 
was the result of formed RBCs microaggregates in 
the sample. These microaggregates the analyser 
may count as WBC or single RBC while, very large 
aggregates may exclude from the count. All of 
these lead to an erroneously low RBC count and, 
consequently, abnormal results of other CBC pa-
rameters (haematocrit, MCV, MCH and MCHC) (3). 
The analyser calculates MCH and MCHC indices us-
ing three measured parameters. Such, MCH is cal-
culated as a quotient of haematocrit and RBC 
count (MCH, pg = Hct/RBC), while MCHC is calcu-
lated as a quotient of haemoglobin and haemato-
crit (MCHC, g/L = Hb/Hct). MCHC might provide a 
mean for quality control of these parameters. High 
MCHC is a good indicator of analysis or sample er-
ror (haemolysis, lipaemia, agglutination of eryth-
rocytes, etc.). Contemporary automated haematol-
ogy analysers display flags to warn for possible er-
rors. In our case, MCHC value was extremely high 
and flags from the analyser indicated RBC aggluti-
nation. Agglutination, usually, can be visually ob-
served, but the blood smear examination is the 
best way to confirm it. The erroneous results were 
corrected after the sample was warmed to 37 ºC. 
Warming the sample leads to elution of IgM anti-
body from the cell surface allowing the agglutinat-
ed RBCs to separate. In a published report by 
Nikousefat et al., a female patient with low RBC 
count, incompatible Hct and Hb, and increased 
RBC indices measured on automated Sysmex ana-
lyser, was diagnosed with CAD and warming the 
sample to 37 ºC led to correct results (8). Similar re-
sults were found in a report described by Ercan S. 
et al. using the ABX Pentra 80 haematology analys-
er (4). They evaluated the CAs antibody titre and 
valid laboratory results were obtained after proper 
sample transport in warmed container and imme-
diate analysis on haematology analyser. Errone-
ously low RBC count, low Htc that did not correlate 
with the Hb concentration and increased RBC indi-
ces in the presence of CAs were also described by 
Kakkar, using Advia 60 haematology analyser, and 
Yasar and Breuer et al., using automated Coulter 
haematology analysers (3,5,9). 
White blood cell and Hb concentrations were un-
affected by CAs. Haemoglobin is measured direct-
ly by the lysis of RBCs in another channel. Concen-
tration can be falsely increased in haemolytic sam-
ples (Sample 1, Table 1). Platelet count and indices 
can be measured incorrectly because Plt can also 
undergo auto-agglutination. Such case is reported 
by Yasar et al. who described unmeasurable Plt 
and MPV, but after warming the sample to 37 ºC 
the parameters were normally measured (3).
Diagnosis of CAD requires further analysis. We per-
formed some of them; direct and indirect anti-
globulin (Coombs) test, serum concentrations of 
immunoglobulins and C3 and C4 components of 
complement. We found positive direct and nega-
tive indirect antiglobulin test and high concentra-
tion of IgM. Positive Coombs test indicated that 
erythrocytes are attached with IgG and/or C3 
component of complement. In the study on 58 pa-
tients, positivity for anti-C3d antibodies was 74%, 
anti-C3d + anti-IgG 22% and anti-IgG 3.4% (10). Ex-
cept the problems with routine laboratory analy-
sis, CAs causes difficulty in blood type detecting. 
Lodi et al. reported the case of 48-year-old patient 
whose blood group was not determined due to 
analytical problems causing by CAs presence in 
patient’s sample and the patient died after receiv-
ing emergency transfusion of universal RBCs (11). 
Cold agglutinins and CAD are rare, according to a 
Norwegian study the prevalence is 16 cases per 
million inhabitants and incidence rate is one per 
million per year. Most often affected are adults in 
the seventh decade of life with slight female pre-
dominance (12). Cold agglutinins are commonly 
IgM antibodies activated at low temperatures. 
Since IgM are the largest human antibodies their 
hexameric (or pentameric) forms have antigen-
binding sites sufficiently far apart to bridge the 
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distance imposed upon RBC in suspensions like 
plasma, thus allowing spontaneous agglutination. 
Cold agglutinins, found in low titres in healthy in-
dividuals, have no activity at temperatures higher 
than 4 ºC. Pathological CAs usually react at 28 to 
31 ºC (13). Blood cell counts might also be affected 
at low temperature by cryoglobulins. Cryoglobu-
lins are circulating immunoglobulins that become 
insoluble and precipitate in temperature between 
4 °C and 37 °C causing analytical interference for 
automated blood cell counters, mainly resulting in 
pseudoleukocytosis and pseudothrombocytosis 
(14-16). Passing through the aperture of the ana-
lyser, cryoglobulin particles might be counted as 
WBCs or Plt when they approximate their size, 
structure, and shape. Unlike CAs, cryoglobulins 
usually slightly affect RBC count and Hb measure-
ment (14). Therefore, CAs and cryoglobulins differ-
entially interfere on blood cell counts, however 
laboratory procedure how to analyse such sam-
ples is the same in both cases.    
What YOU should / can do in your 
laboratory to prevent such errors
A proposed laboratory procedure to easily detect 
and prevent preanalytical errors caused by CAs 
presence in whole blood samples is presented in 
Figure 2.
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